Sector ratings Amgen Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-10 pm EDT			5-day change	1st Jan Change
351.02 ^USD	-1.29%		+0.89%	+7.24%

Apr. 10	BeOne Medicines Says Tarlatamab Received Marketing Authorization in China for Small Cell Lung Cancer Treatment	MT
Apr. 10	Wall Street Gets a CPI Lifeline

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
AMGEN INC.	189B		A
ELI LILLY AND COMPANY	841B		A
JOHNSON & JOHNSON	574B		BBB
ABBVIE INC.	368B		AA
ROCHE HOLDING AG	320B		AA			-		-
ASTRAZENECA PLC	318B		A
MERCK & CO., INC.	300B		A
NOVARTIS AG	295B		AAA
GILEAD SCIENCES, INC.	173B		AA
NOVO NORDISK A/S	168B		A
PFIZER INC.	153B		A
BRISTOL-MYERS SQUIBB COMPANY	120B		A
GSK PLC	117B		AA
SANOFI	114B		AA
VERTEX PHARMACEUTICALS INCORPORATED	111B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	89.72B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	56.91B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	55.4B		AA
BAYER AG	46.27B		AA
Average	223.6B		AA
Weighted average by Cap.			AA